A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues
Abstract Cardiotoxicity of pharmaceutical drugs, industrial chemicals, and environmental toxicants can be severe, even life threatening, which necessitates a thorough evaluation of the human response to chemical compounds. Predicting risks for arrhythmia and sudden cardiac death accurately is critic...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75b6c068a5ce412c8a3e790024a14557 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:75b6c068a5ce412c8a3e790024a14557 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:75b6c068a5ce412c8a3e790024a145572021-12-02T16:50:31ZA predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues10.1038/s41598-021-89478-92045-2322https://doaj.org/article/75b6c068a5ce412c8a3e790024a145572021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89478-9https://doaj.org/toc/2045-2322Abstract Cardiotoxicity of pharmaceutical drugs, industrial chemicals, and environmental toxicants can be severe, even life threatening, which necessitates a thorough evaluation of the human response to chemical compounds. Predicting risks for arrhythmia and sudden cardiac death accurately is critical for defining safety profiles. Currently available approaches have limitations including a focus on single select ion channels, the use of non-human species in vitro and in vivo, and limited direct physiological translation. We have advanced the robustness and reproducibility of in vitro platforms for assessing pro-arrhythmic cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes and human cardiac fibroblasts in 3-dimensional microtissues. Using automated algorithms and statistical analyses of eight comprehensive evaluation metrics of cardiac action potentials, we demonstrate that tissue-engineered human cardiac microtissues respond appropriately to physiological stimuli and effectively differentiate between high-risk and low-risk compounds exhibiting blockade of the hERG channel (E4031 and ranolazine, respectively). Further, we show that the environmental endocrine disrupting chemical bisphenol-A (BPA) causes acute and sensitive disruption of human action potentials in the nanomolar range. Thus, this novel human 3D in vitro pro-arrhythmic risk assessment platform addresses critical needs in cardiotoxicity testing for both environmental and pharmaceutical compounds and can be leveraged to establish safe human exposure levels.Celinda M. KofronTae Yun KimFabiola MunarinArvin H. SoepriatnaRajeev J. KantUlrike MendeBum-Rak ChoiKareen L. K. CoulombeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Celinda M. Kofron Tae Yun Kim Fabiola Munarin Arvin H. Soepriatna Rajeev J. Kant Ulrike Mende Bum-Rak Choi Kareen L. K. Coulombe A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
description |
Abstract Cardiotoxicity of pharmaceutical drugs, industrial chemicals, and environmental toxicants can be severe, even life threatening, which necessitates a thorough evaluation of the human response to chemical compounds. Predicting risks for arrhythmia and sudden cardiac death accurately is critical for defining safety profiles. Currently available approaches have limitations including a focus on single select ion channels, the use of non-human species in vitro and in vivo, and limited direct physiological translation. We have advanced the robustness and reproducibility of in vitro platforms for assessing pro-arrhythmic cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes and human cardiac fibroblasts in 3-dimensional microtissues. Using automated algorithms and statistical analyses of eight comprehensive evaluation metrics of cardiac action potentials, we demonstrate that tissue-engineered human cardiac microtissues respond appropriately to physiological stimuli and effectively differentiate between high-risk and low-risk compounds exhibiting blockade of the hERG channel (E4031 and ranolazine, respectively). Further, we show that the environmental endocrine disrupting chemical bisphenol-A (BPA) causes acute and sensitive disruption of human action potentials in the nanomolar range. Thus, this novel human 3D in vitro pro-arrhythmic risk assessment platform addresses critical needs in cardiotoxicity testing for both environmental and pharmaceutical compounds and can be leveraged to establish safe human exposure levels. |
format |
article |
author |
Celinda M. Kofron Tae Yun Kim Fabiola Munarin Arvin H. Soepriatna Rajeev J. Kant Ulrike Mende Bum-Rak Choi Kareen L. K. Coulombe |
author_facet |
Celinda M. Kofron Tae Yun Kim Fabiola Munarin Arvin H. Soepriatna Rajeev J. Kant Ulrike Mende Bum-Rak Choi Kareen L. K. Coulombe |
author_sort |
Celinda M. Kofron |
title |
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
title_short |
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
title_full |
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
title_fullStr |
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
title_full_unstemmed |
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues |
title_sort |
predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3d cardiac microtissues |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/75b6c068a5ce412c8a3e790024a14557 |
work_keys_str_mv |
AT celindamkofron apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT taeyunkim apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT fabiolamunarin apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT arvinhsoepriatna apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT rajeevjkant apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT ulrikemende apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT bumrakchoi apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT kareenlkcoulombe apredictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT celindamkofron predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT taeyunkim predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT fabiolamunarin predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT arvinhsoepriatna predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT rajeevjkant predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT ulrikemende predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT bumrakchoi predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues AT kareenlkcoulombe predictiveinvitroriskassessmentplatformforproarrhythmictoxicityusinghuman3dcardiacmicrotissues |
_version_ |
1718383045893947392 |